CB Insights
Technology Market Intelligence
Technology Market Intelligence
| Date | Company | Round | Amount | Co-investors |
|---|---|---|---|---|
| 2019-10-15 | Cyteir Therapeutics | Series B - II | $40.2M | Celgene, DROIA Oncology Ventures, Lightstone Ventures, Osage University Partners, and Venrock |
| 2019-09-11 | Anokion | Series B | $40M | Celgene, Novartis Venture Funds, and Versant Ventures |
| 2019-09-04 | Nkarta | Series B | $114M | Amgen Ventures, Deerfield Management, Life Sciences Partners, Logos Capital, New Enterprise Associates, RA Capital Management, Samsara BioCapital, and SR One |
| 2019-08-22 | Arcellx | Series A | $85M | New Enterprise Associates, Quan Capital (泉创资本), and SR One |
| 2019-08-22 | Harmony Biosciences | Unattributed VC - III | $50M | HBM Healthcare Investments, Valor Equity Partners, venBIO, and Vivo Capital |
